flortaucipir F18: Clinical Trials

3 trials of flortaucipir F18, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow flortaucipir F18: new trials by email Literature Review of flortaucipir F18 trials Research Report on flortaucipir F18

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
flortaucipir F18, Brain PET Scan - Alzheimer Disease
Phase 3CompletedAvid Radiopharmaceuticals2052019-03-282020-08-28
18F-AV-1451 Autopsy Study
Flortaucipir F18, PET Scan - Alzheimer's Disease
Phase 3CompletedAvid Radiopharmaceuticals1562015-09-012020-09-07
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
florbetapir F 18, Flortaucipir F18, Brain PET Scan - Alzheimer's Disease
Phase 2 / Phase 3CompletedAvid Radiopharmaceuticals3832013-12-012020-09-22

Conditions studied

Alzheimer Disease (3)

Sponsors

Avid Radiopharmaceuticals (3)

Countries

United States (3)  ·  Australia (1)

Results publications

PMID 33587110, PMID 32338734, PMID 32542468